Interview with Juan Craveri, President and CEO, Craveri
Craveri has one of the most distinguished histories of any of the Argentine pharmaceutical companies, with over 120 years of history. Three generations after it’s foundation, do you feel you…
Address: Arengreen 830 (C1405CYH), Buenos Aires,Argentina
Tel: +54 11 5453-4555
Web: http://www.craveri.com.ar/
One of the oldest pharmaceutical companies in Argentina, Craveri is a family-run company which is one of the forerunners in repositioning itself in order to best face the challenges of the pharmaceutical industry in the 21st century. Since 1996, the company has been involved with bioengineering, and was the first company in Argentina to help develop skin replacement treatments. Combined with their more traditional products, Craveri is well-positioned for growth and success in the years to come.
Diabetology, Phlebology, Neurology, Cardiovascular Disorders, Gastroenterology and Obesity
Craveri has one of the most distinguished histories of any of the Argentine pharmaceutical companies, with over 120 years of history. Three generations after it’s foundation, do you feel you…
Florencia Davel, head of LatAm operations for Bristol Myers Squibb (BMS) looks back on a successful four years in position, shaping the regional organisation into a true biopharma player in…
The Head of Viatris Latin America, Patrick Doyle, spoke to PharmaBoardroom about setting up the two-year old company’s Latam affiliate during the pandemic, the decision to focus on specific therapeutic…
Boehringer Ingelheim’s managing director for South America, Dirk van Niekerk, provides an overview of the healthcare climate in South America, the challenges tied to political and economic instability, future opportunities…
Dr Guillermo Chantada, incoming president-elect of the International Society of Paediatric Oncology (SIOP) highlights the progress of paediatric oncology in Latin America and gives a call to arms to the…
PharmaBoardroom spoke to Fabrice Chouraqui, President of Novartis Latin America and Canada at the Financial Times LatAm Healthcare & Life Sciences Summit in September 2015. He emphasizes the criticality of…
The national coordinator of Plan Nacer and Plan Sumar – two social security programs to improve access to healthcare in Argentina – discusses universal coverage as a constitutional right, and the…
A senior director for Icon plc discusses Argentina’s strengths and weaknesses as a venue for clinical trials, the role the market plays in a global clinical trial strategy, and Icon’s…
Dr. Wanda Dobrzanski discusses Argentina’s potential and attractiveness as a clinical research environment and the biggest challenges facing local and global CROs in Argentina. How has political and popular…
Gador’s first general director from outside of the family discusses his mission, Gador’s key to success, and his method for successfully leading a company in Argentina’s unpredictable and volatile market.…
The founder of Eriochem discusses his firm’s ambitious technology based on a competitive IP strategy and its exciting research on a radically new oncology platform. Today, Eriochem is a vertically…
The general manager of IMS Health Argentina – South Cone weighs in on why his organization plays a crucial role in the pharma industry in Argentina. How does the Argentinean…
Dr. Valverde, a respected authority on pharmacovigilance from the University of Mamonides, discusses the emerging pharmaceutical trade relationship between China and Argentina in the context of the dynamic Argentinian industry.…
See our Cookie Privacy Policy Here
